ImmunityBio (IBRX) Amortizatization of Intangibles (2015 - 2026)
ImmunityBio (IBRX) posted quarterly Amortizatization of Intangibles of $1.5 million for Q1 2026, up 2834.62% year-over-year from $52000.0 in Q1 2025, and down 10.45% quarter-over-quarter from $1.7 million in Q4 2025.
Powered by 
Analysis
ImmunityBio (IBRX) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Amortizatization of Intangibles for 12 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 2834.62% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $4.2 million (up 301.81% YoY), while the FY2025 annual figure was $2.7 million, up 84.35% from the prior year.
- Amortizatization of Intangibles eased to $1.5 million in Q1 2026 per IBRX's latest filing, from $1.7 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.7 million in Q4 2025 and bottomed at -$10000.0 in Q3 2022.
- Historically, Amortizatization of Intangibles has averaged $490583.3 across 5 years, with a median of $257500.0 in 2023.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 7000.0% in 2025 and fell as far as 97.21% in 2025.
- ImmunityBio's Amortizatization of Intangibles stood at -$10000.0 in 2022, then surged by 1310.0% to $121000.0 in 2023, then plunged by 80.17% to $24000.0 in 2024, then surged by 7000.0% to $1.7 million in 2025, then declined by 10.45% to $1.5 million in 2026.
- Business Quant data shows IBRX's Amortizatization of Intangibles at $1.5 million in Q1 2026, $1.7 million in Q4 2025, and $978000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | ImmunityBio | 8.51 Bn | 8.15 Bn | 50.94 Mn | 2.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.27 Mn |
| Mar 31, 2026 | 1.53 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | 978,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | 580,000.00 |
| Jun 30, 2024 | 394,000.00 |
| Mar 31, 2024 | 491,000.00 |
| Dec 31, 2023 | -4.65 Mn |
| Sep 30, 2023 | 1.55 Mn |
| Jun 30, 2023 | 1.64 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.65 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 1.32 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | 1.23 Mn |